Last updated on November 2019

A 24-week multicenter, randomized, double-blind, parallel-group study comparing the efficacy and safety of ixekizumab to guselkumab in patients with moderate-to-severe plaque psoriasis.

Other Details:

For more information, visit

Find a site near you

Start Over

Dermatology Physicians of Connecticut

Located in: Shelton, Connecticut United States
  Connect »